Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.79 USD | +1.94% | +3.99% | -12.64% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |